Activation of the β-TrCP/IκBα/inflammation axis limits the sensitivity of liver cancer cells to neddylation inhibition.
- Published in:
- Oncology Reports, 2022, v. 48, n. 5, p. N.PAG, doi. 10.3892/or.2022.8416
- By:
- Publication type:
- Article
Works matching IS 1021335X AND DT 2022 AND VI 48 AND IP 5
Results: 19
1
2
Tumor suppressor role of miR-217 in human epithelial ovarian cancer by targeting IGF1R.
- Published in:
- Oncology Reports, 2022, v. 48, n. 5, p. N.PAG, doi. 10.3892/or.2022.8415
- By:
- Publication type:
- Article
3
MicroRNA-379-5p plays a tumor-suppressive role in human bladder cancer growth and metastasis by directly targeting MDM2.
- Published in:
- Oncology Reports, 2022, v. 48, n. 5, p. N.PAG, doi. 10.3892/or.2022.8413
- By:
- Publication type:
- Article
4
Sulforaphane has an additive anticancer effect to FOLFOX in highly metastatic human colon carcinoma cells.
- Published in:
- Oncology Reports, 2022, v. 48, n. 5, p. N.PAG, doi. 10.3892/or.2022.8420
- By:
- Publication type:
- Article
5
OTX1 promotes tumorigenesis and progression of cervical cancer by regulating the Wnt signaling pathway.
- Published in:
- Oncology Reports, 2022, v. 48, n. 5, p. N.PAG, doi. 10.3892/or.2022.8419
- By:
- Publication type:
- Article
6
MYCL promotes the progression of triple-negative breast cancer by activating the JAK/STAT3 pathway.
- Published in:
- Oncology Reports, 2022, v. 48, n. 5, p. N.PAG, doi. 10.3892/or.2022.8418
- By:
- Publication type:
- Article
7
Gomisin A enhances the antitumor effect of paclitaxel by suppressing oxidative stress in ovarian cancer.
- Published in:
- Oncology Reports, 2022, v. 48, n. 5, p. N.PAG, doi. 10.3892/or.2022.8417
- By:
- Publication type:
- Article
8
Circadian as a prognostic factor for radiation responses in patients with cervical cancer: A nested case-control study.
- Published in:
- Oncology Reports, 2022, v. 48, n. 5, p. N.PAG, doi. 10.3892/or.2022.8414
- By:
- Publication type:
- Article
9
HMGB1 promotes the development of castration-resistant prostate cancer by regulating androgen receptor activation.
- Published in:
- Oncology Reports, 2022, v. 48, n. 5, p. N.PAG, doi. 10.3892/or.2022.8412
- By:
- Publication type:
- Article
10
Dysregulated circular RNAs are closely linked to multiple myeloma prognosis, with circ_0026652 predicting bortezomib-based treatment response and survival via the microRNA-608-mediated Wnt/β-catenin pathway.
- Published in:
- Oncology Reports, 2022, v. 48, n. 5, p. N.PAG, doi. 10.3892/or.2022.8410
- By:
- Publication type:
- Article
11
TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma.
- Published in:
- Oncology Reports, 2022, v. 48, n. 5, p. N.PAG, doi. 10.3892/or.2022.8411
- By:
- Publication type:
- Article
12
miR-370 regulates cell proliferation and migration by targeting EGFR in gastric cancer.
- Published in:
- Oncology Reports, 2022, v. 48, n. 5, p. N.PAG, doi. 10.3892/or.2022.8409
- By:
- Publication type:
- Article
13
Intra-tumor heterogeneity of cancer stem cell-related genes and their potential regulatory microRNAs in metastasizing colorectal carcinoma.
- Published in:
- Oncology Reports, 2022, v. 48, n. 5, p. N.PAG, doi. 10.3892/or.2022.8408
- By:
- Publication type:
- Article
14
Clinical implications of the oral-gut microbiome axis and its association with colorectal cancer.
- Published in:
- Oncology Reports, 2022, v. 48, n. 5, p. N.PAG, doi. 10.3892/or.2022.8407
- By:
- Publication type:
- Article
15
MicroRNA-218 inhibits tumor angiogenesis of human renal cell carcinoma by targeting GAB2.
- Published in:
- Oncology Reports, 2022, v. 48, n. 5, p. N.PAG, doi. 10.3892/or.2022.8406
- By:
- Publication type:
- Article
16
In vitro characterization and rational analog design of a novel inhibitor of telomerase assembly in MDA MB 231 breast cancer cell line.
- Published in:
- Oncology Reports, 2022, v. 48, n. 5, p. N.PAG, doi. 10.3892/or.2022.8403
- By:
- Publication type:
- Article
17
Wnt2b and Wnt5a expression is highly associated with M2 TAMs in non-small cell lung cancer.
- Published in:
- Oncology Reports, 2022, v. 48, n. 5, p. N.PAG, doi. 10.3892/or.2022.8404
- By:
- Publication type:
- Article
18
A guide through conventional and modern cancer treatment modalities: A specific focus on glioblastoma cancer therapy.
- Published in:
- Oncology Reports, 2022, v. 48, n. 5, p. N.PAG, doi. 10.3892/or.2022.8405
- By:
- Publication type:
- Article
19
miR-365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinoma.
- Published in:
- Oncology Reports, 2022, v. 48, n. 5, p. N.PAG, doi. 10.3892/or.2022.8402
- By:
- Publication type:
- Article